Appendix 2—table 17. “Bone-Rx” Cohort (All Regions), Patient Characteristics Pre/Post Match.
| "Bone-Rx" Cohort / All Observations Unmatched | "Bone-Rx" Cohort / All Observations Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 502,895 | 100.0% | 50,844 | 10.1% | 452,051 | 89.9% | 100,996 | 100.0% | 50,498 | 50.0% | 50,498 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 1,164 | 0.2% | 36 | 0.1% | 1,128 | 0.2% | <0.001 | 67 | 0.1% | 36 | 0.1% | 31 | 0.1% | 0.97 |
| 21-40 | 3,501 | 0.7% | 410 | 0.8% | 3,091 | 0.7% | 790 | 0.8% | 403 | 0.8% | 387 | 0.8% | ||
| 41-50 | 9,631 | 1.9% | 1,080 | 2.1% | 8,551 | 1.9% | 2,107 | 2.1% | 1,069 | 2.1% | 1,038 | 2.1% | ||
| 51-60 | 72,139 | 14.3% | 6,418 | 12.6% | 65,721 | 14.5% | 12,777 | 12.7% | 6,395 | 12.7% | 6,382 | 12.6% | ||
| 61-70 | 171,687 | 34.1% | 14,809 | 29.1% | 156,878 | 34.7% | 29,509 | 29.2% | 14,751 | 29.2% | 14,758 | 29.2% | ||
| 71-80 | 157,877 | 31.4% | 16,152 | 31.8% | 141,725 | 31.4% | 32,129 | 31.8% | 16,055 | 31.8% | 16,074 | 31.8% | ||
| ≥81 | 86,896 | 17.3% | 11,939 | 23.5% | 74,957 | 16.6% | 23,617 | 23.4% | 11,789 | 23.3% | 11,828 | 23.4% | ||
| Gender | ||||||||||||||
| Female | 451,790 | 89.8% | 44,354 | 87.2% | 407,436 | 90.1% | <0.001 | 88,552 | 87.7% | 44,235 | 87.6% | 44,317 | 87.8% | 0.43 |
| Male | 51,105 | 10.2% | 6,490 | 12.8% | 44,615 | 9.9% | 12,444 | 12.3% | 6,263 | 12.4% | 6,181 | 12.2% | ||
| Region | ||||||||||||||
| Midwest | 85,391 | 17.0% | 9,424 | 18.5% | 75,967 | 16.8% | <0.001 | 18,720 | 18.5% | 9,360 | 18.5% | 9,360 | 18.5% | 1.00 |
| Northeast | 135,867 | 27.0% | 16,139 | 31.7% | 119,728 | 26.5% | 31,986 | 31.7% | 15,993 | 31.7% | 15,993 | 31.7% | ||
| South | 178,118 | 35.4% | 17,232 | 33.9% | 160,886 | 35.6% | 34,280 | 33.9% | 17,140 | 33.9% | 17,140 | 33.9% | ||
| West | 103,519 | 20.6% | 8,049 | 15.8% | 95,470 | 21.1% | 16,010 | 15.9% | 8,005 | 15.9% | 8,005 | 15.9% | ||
| Insurance | ||||||||||||||
| Commercial | 164,150 | 32.6% | 17,092 | 33.6% | 147,058 | 32.5% | <0.001 | 33,977 | 33.6% | 16,963 | 33.6% | 17,014 | 33.7% | 0.91 |
| Dual | 33,969 | 6.8% | 2,562 | 5.0% | 31,407 | 6.9% | 5,056 | 5.0% | 2,547 | 5.0% | 2,509 | 5.0% | ||
| Medicaid | 84,514 | 16.8% | 7,034 | 13.8% | 77,480 | 17.1% | 13,925 | 13.8% | 6,986 | 13.8% | 6,939 | 13.7% | ||
| Medicare | 220,262 | 43.8% | 24,156 | 47.5% | 196,106 | 43.4% | 48,038 | 47.6% | 24,002 | 47.5% | 24,036 | 47.6% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 181,996 | 36.2% | 18,130 | 35.7% | 163,866 | 36.2% | 0.009 | 35,943 | 35.6% | 17,979 | 35.6% | 17,964 | 35.6% | 0.92 |
| Yes | 320,899 | 63.8% | 32,714 | 64.3% | 288,185 | 63.8% | 65,053 | 64.4% | 32,519 | 64.4% | 32,534 | 64.4% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.05 | 1.91 | 1.99 | 2.71 | 0.95 | 1.76 | <0.001 | 1.93 | 2.59 | 1.93 | 2.60 | 1.92 | 2.59 | 0.76 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.